Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Solid Biosciences Inc. (SLDB) had Cash Flow from Financial Activities of $189.30M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-45.78M |
|
-- |
|
-- |
|
$48.06M |
|
$-48.06M |
|
$2.28M |
|
$-45.78M |
|
$-45.78M |
|
$-45.78M |
|
$-45.78M |
|
$-45.78M |
|
$-45.78M |
|
$-48.06M |
|
$-48.01M |
|
94.42M |
|
94.42M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$244.85M |
|
$4.36M |
|
$29.06M |
|
$273.91M |
|
$36.34M |
|
-- |
|
$19.62M |
|
$55.97M |
|
$217.95M |
|
$217.95M |
|
$217.95M |
|
77.88M |
|
| Cash Flow Statement Financials | |
$-102.73M |
|
$-105.47M |
|
|
Cash Flow from Financial Activities |
$189.30M |
$82.19M |
|
$63.29M |
|
$-18.90M |
|
$10.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.74 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-103.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.00% |
|
-21.00% |
|
-16.71% |
|
-21.00% |
|
$2.80 |
|
$-1.09 |
|
$-1.09 |
|